Comparative Efficacy and Safety if Intravesical Botulinum Toxin A Versus Platelet-Rich Plasma in the Management of Refractory Overactive Bladder : A 2 Year Study
Clinical trial NCT07693192 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07693192
- Sponsor
- Mahmoud Mohamed Farag Ali
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-01
- Primary completion
- 2026-12-01
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.